@article{c6167d592c5a4b5588a13c83eebc7cec,
title = "Erratum: A budget impact analysis of gene therapy for sickle cell disease: The Medicaid perspective (JAMA Pediatr. (2021) DOI: 10.1001/jamapediatrics.2020.7140)",
abstract = "Error in the Text: In the Original Investigation titled “A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective,” which published online March 22, 2021,1 there was an error in the Introduction section. The third sentence in the fourth paragraph of that section should read: “Agene therapy using the same lentiviral vector received conditional approval from the European Medicines Agency in 2019for the treatment of transfusion-dependent {\ss}-thalassemia.”This article was corrected online.",
author = "P. Demartino and Haag, {M. B.} and Hersh, {A. R.} and Caughey, {A. B.} and Roth, {J. A.}",
note = "Funding Information: Conflict of Interest Disclosures: Dr Tidblad reported personal fees from Pfizer outside the submitted work. Dr S{\"a}vendahl reported grants from Regional University Hospital grants paid to Karolinska University Hospital and the Swedish Research Council paid to Karolinska Institutet during the conduct of the study; personal fees from Ascendis Honorarium, Hexal Lecture, Merck Lecture, Novo Nordisk Honorarium, Pfizer, and Sandoz Honorarium outside the submitted work. No other disclosures were reported. Publisher Copyright: {\textcopyright} 2021 American Medical Association. All rights reserved.",
year = "2021",
month = jun,
doi = "10.1001/jamapediatrics.2021.1438",
language = "English (US)",
volume = "175",
pages = "647",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "6",
}